Global Dermatology Drugs Market: Overview
The global market for dermatological
drugs covers within its purview a large number of drug classes that are
employed for treating the vast variety of diseases related to skin,
nail, genital membranes, and hair affecting millions of people globally.
It has been observed in the recent years that the pool of patients
affected by dermatological conditions has massively expanded owing to
factors such as nutritional deficiency, unhealthy food habits, rise in
stress, pollution, and lack of immunity in the global population. With
this has increased the demand for effective treatment methods and
dermatological drugs for the treatment of dermatological conditions.
Coupled with the rising demand for
effective dermatological treatments, the rise in number of companies
investing in the market, a significant increase in the number of drug
classes available, and the plausible pace of research and development
practices helped the global dermatological drugs market pick pace. The
market is likely to see a healthy growth trajectory in the next few
years as well, thanks to increased awareness among patients regarding
available courses of treatment for dermatological conditions and rising
expenditure on skin and haircare products. While effective surgical
treatments are available for common dermatology conditions, dermatology
drugs are preferred owing to their inexpensive nature and easy
availability across all regional markets.
Global Dermatology Drugs Market: Segmentation
The report covers the global dermatology
drugs market for aspects such as end-use, route of administration,
therapeutic application, and geography. Based on the route of
administration, the report segments the global dermatology market into
parenteral, topical, and oral. On the basis of therapeutic application,
the report segments the global dermatology drugs market into skin
cancer, dermatitis, skin infection, acne vulgaris, rosacea alopecia,
eczema, fungal infection, and hair loss. On the basis of end-use of
dermatology drugs, the global market has been segmented into cosmetic
centers, specialty clinics, and hospitals.
Global Dermatology Drugs Market: Geographical and Competitive Dynamics
From a geographical standpoint, the
report covers the market for dermatology drugs across regions such as
Latin America, North America, Asia Pacific, Europe, and Rest of the
World. Of these regional segments, the markets in Europe and North
America are presently the leading contributors of revenue to the global
market owing to the vast patient pool of a vast variety of
dermatological conditions and willingness of patients to pay for
expensive medications.
Over the next few years, the market in
regions such as Asia Pacific and Rest of the World are likely to emerge
as highly promising markets for dermatology drugs owing to the high
incidence rate of conditions such as acne and psoriasis. Other factors,
such as the rising willingness to adopt advanced and expensive
therapeutics, rising investment in the sector of manufacturing, and
rising awareness about dermatological conditions and their possible
treatments among the population.
In the largely fragmented and immensely
competitive vendor landscape of the global dermatology drugs market,
some of the leading companies are GlaxoSmithKline, Johnson & Johnson
Services Inc., AstraZeneca, AbbVie Inc., LEO Pharma A/S, and Pfizer,
Inc.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment